Initia is proud to announce new clinical results unveiled at the European Association of Urology (EAU) 2025 Congress, where Dr. Ruben Muñoz presented a groundbreaking study on the treatment of distal ureteral stones using the Integra ESWL system. The findings highlight a significant advancement in extracorporeal shockwave lithotripsy and reinforce Integra’s position as a leading technology in non-invasive urolithiasis treatment.
Innovative ESWL Technique for Ureteral Stones
The study showcases an innovative technique in which the patient is positioned to allow the shockwave to pass through the pelvic foramen, enabling precise energy delivery directly to the ureter. This optimized pathway enhances stone visualization, fragmentation efficiency, and overall treatment success—key priorities in urological stone management.
Strong Clinical Results Using Integra Shockwave Technology
The clinical research included 150 patients treated between March 2019 and July 2024. The results demonstrate the reliability and performance of the Integra system:
- 78% stone-free rate
- Only 12 retreatments, significantly lower than typical ESWL benchmarks
- Average stone size: 4–10 mm
- Treatment duration: 12–35 minutes
- Shock frequency: 80 shocks/min
- Hospital stay: 30–40 minutes
These outcomes highlight Integra’s strong clinical performance in ureteral stone fragmentation and reinforce its role as a reliable, effective ESWL solution.
Reinforcing the Role of ESWL in Modern Urology
With many urologists exploring alternatives to ESWL due to variable efficacy from older technologies, this research confirms that high-intensity electromagnetic shockwave systems like Integra can transform patient outcomes. Benefits include:
- Non-invasive stone treatment
- Reduced procedural costs and shorter hospital stays
- Improved patient comfort and recovery
- Enhanced precision and reliability
These advantages make Integra a valuable tool for clinics seeking effective, efficient, and cost-conscious options in kidney and ureteral stone therapy.
Driving Innovation in Urological Care
We congratulate Dr. Ruben Muñoz for contributing meaningful clinical evidence that advances the field of urolithiasis management. His findings showcase the power of the Integra ESWL system and reinforce its role in delivering superior outcomes in ureteral stone treatment.
Initia remains committed to supporting urologists worldwide with cutting-edge technologies that elevate clinical performance and improve patient care.